Angiotensin 1-7: A Novel Strategy in COVID-19 Treatment

Hamed Imanpour ¹ , Haleh Rezaee ^2,3 , Masoud Nouri-Vaskeh ^4,5 *

Cited by CrossRef: 13

1- Nouri‐Vaskeh M, Kalami N, Zand R, Soroureddin Z, Varshochi M, Ansarin K, Rezaee H, Taghizadieh A, Sadeghi A, Ahangari Maleki M, Esmailnajad A, Saleh P, Haghdoost M, Maleki M, Sharifi A. Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial. Int J Clin Pract. 2021;75(6) [Crossref]

2- Chi L, Asgharpour S, Correa-Basurto J, Bandala C, Martínez-Archundia M. Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations. J Comput Aided Mol Des. 2022;36(9):653 [Crossref]

3- Roosta Y, Behzadi F, Askari E, Raeisi M, Danandeh Mehr A, Nouri-Vaskeh M. Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges. Leukemia Research Reports. 2021;15:100239 [Crossref]

4- Wehbe Z, Hammoud S, Yassine H, Fardoun M, El-Yazbi A, Eid A. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality. Front Immunol. 2021;12 [Crossref]

5- Brandini D, Takamiya A, Thakkar P, Schaller S, Rahat R, Naqvi A. Covid‐19 and oral diseases: Crosstalk, synergy or association?. Reviews in Medical Virology. 2021;31(6) [Crossref]

6- Rezaee H, Pourkarim F, Pourtaghi‐Anvarian S, Entezari‐Maleki T, Asvadi‐Kermani T, Nouri‐Vaskeh M. Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview. Pharmacology Res & Perspec. 2021;9(1) [Crossref]

7- ÜNAL ÇETİN E, BEYAZIT Y, BEYAZIT F, TANOĞLU A, HAZNEDAROĞLU İ. The pathobiological harmony between the local pulmonary/ bone marrow RAS and its management via tissue-RAS modulating agents in COVID-19. 2022;5(3):932 [Crossref]

8- Luna P, Fernanda Pérez M, Castellar-Lopez J, Chang A, Montoya Y, Bustamante J, Rosales-Rada W, Mendoza-Torres E. Potential of Angiotensin-(1-7) in COVID-19 Treatment. CPPS. 2023;24(1):89 [Crossref]

9- Rostamzadeh F, Najafipour H, Nakhaei S, Yazdani R, Langari A. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19. 2023;18(1) [Crossref]

10- Dean A, Bozza W, Twomey J, Luo S, Nalli A, Zhang B. The fight against COVID-19: Striking a balance in the renin–angiotensin system. Drug Discovery Today. 2021;26(10):2214 [Crossref]

11- Nouri-Vaskeh M, Sharifi A, Khalili N, Zand R, Sharifi A. Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism. Clinical Neurology and Neurosurgery. 2020;198:106217 [Crossref]